Besides, Ocoxin reduces the secretion of proinflammatory mediators LGALS1, OPN, CCL5, and CCL9 chemokines by melanoma cells, which could result in a reduction of the recruitment and differentiation of mesenchymal stem cells into CAFs and decreased resistance to anticancer drugs of cancer cells [53,54]. The gene discussed is CCL5; the disease is melanoma.